Skip to content

AptarGroup ATR Return on equity

Return on equity at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
19.1%+1.7pp
Amcor logo
AmcorAMCR
8.7%-12.0pp
Nordson logo
NordsonNDSN
17.1%+1.6pp
Baxter International logo
Baxter InternationalBAX
-16.7%-76.7pp
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
124.5%+12.7pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
16.9%

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Calculated from AptarGroup’s reported figures.

Based on trailing twelve months.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's return on equity?
AptarGroup (ATR) reported return on equity of 15% in Q1 2026.
How has AptarGroup's return on equity changed year-over-year?
AptarGroup's return on equity decreased by 1.2% year-over-year, from 15.2% to 15%.
What is the long-term trend for AptarGroup's return on equity?
Over 5 years (2020 to 2025), AptarGroup's return on equity has grown at a 4.1% compound annual growth rate (CAGR), from 12.5% to 15.3%.
What does return on equity mean?
How much profit the company earns on the money shareholders have invested.
How do you interpret return on equity?
Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
How does return on equity compare across companies?
Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.